Cansino Biologics Inc (688185) — Cash Flow-to-Debt Ratio
Cansino Biologics Inc (688185) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥30.53 Million could theoretically repay 0% of its total liabilities (CN¥2.37 Billion) in one year. See free cash flow generation of Cansino Biologics Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cansino Biologics Inc Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Cansino Biologics Inc across 9 annual periods. Also explore how fast is Cansino Biologics Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cansino Biologics Inc (2016–2024)
Year-by-year debt coverage analysis for Cansino Biologics Inc. For market capitalisation and broader financial context, see Cansino Biologics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | CN¥-168.79 Million | CN¥3.05 Billion | ▲ +75.6% |
| 2023 | -0.23x | CN¥-916.25 Million | CN¥4.03 Billion | ▲ +49.1% |
| 2022 | -0.45x | CN¥-1.89 Billion | CN¥4.22 Billion | ▼ -173.8% |
| 2021 | 0.61x | CN¥2.01 Billion | CN¥3.33 Billion | ▲ +187.4% |
| 2020 | -0.69x | CN¥-469.39 Million | CN¥677.22 Million | ▼ -27.9% |
| 2019 | -0.54x | CN¥-170.19 Million | CN¥313.98 Million | ▼ -28.7% |
| 2018 | -0.42x | CN¥-123.64 Million | CN¥293.56 Million | ▼ -93.8% |
| 2017 | -0.22x | CN¥-56.30 Million | CN¥259.03 Million | ▲ +29.4% |
| 2016 | -0.31x | CN¥-34.38 Million | CN¥111.70 Million | — |